Adrenomedullin expression in coronary circulation after stent implantation as a prognostic factor for restenosis

International Journal of Cardiovascular Interventions

Volumn 5, Issue 4, 2003, Pages 190-194

  Hojo, Yukihiro ^a   Ikeda, Uichi ^a   Mizuno, Osamu ^a   Katsuki, Taka Aki ^a   Shimada, Kazuyuki ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Coronary intervention; Inflammation; Vasodilatation

Indexed keywords

ADRENOMEDULLIN;

ADULT; AGED; ARTERIAL BLOOD; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY SINUS; FEMALE; FEMORAL ARTERY; HUMAN; INFLAMMATION; ISCHEMIC HEART DISEASE; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS; RESTENOSIS; STENT;

ADRENOMEDULLIN; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CASE-CONTROL STUDIES; CORONARY ANGIOGRAPHY; CORONARY CIRCULATION; CORONARY RESTENOSIS; CORONARY STENOSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PEPTIDES; PROGNOSIS; STENTS; TIME FACTORS; VASODILATOR AGENTS;

EID: 0346271871     PISSN: 14628848     EISSN: None     Source Type: Journal    
DOI: 10.1080/14628840310019607     Document Type: Article

References (36)

1. Sirnes PA, Golf S, Myreng Y, et al. Stenting in chronic coronary occlusion (SICCO): a randomized, controlled trial of adding stent implantation after successful angioplasty. J Am Coll Cardiol 1996; 28: 1444-51.
2. Betriu A, Masotti M, Serra A, et al. Randomized comparison of coronary stent implantation and balloon angioplasty in the treatment of de novo coronary artery lesions (START): a four-year follow-up. J Am Coll Cardiol 1999; 34: 1498-506.
3. Hennessy T, Codd M, McCann H, McCarthy D, Sugrue D. Coronary stenting in clinical practice: patient profile, immediate outcome, clinical and angiographic follow-up in 243 consecutive patients. J Invas Cardiol 1997; 9: 257-62.
4. Emanuelsson H, Serruys PW, van Der Giessen WJ, et al. Clinical and angiographical results with multi-link coronary stent system: the West European stent trial (WEST). J Invas Cardiol 1997; 9: 561-68.
5. Anderson PG, Bajaj RK, Baxley WA, Roubin GS. Vascular pathology of balloon-expandable coil stents in humans. J Am Coll Cardiol 1992; 19: 372-81.
6. Komatsu R, Ueda M, Naruko T, Kojima A, Becker AE. Neointimal tissue response at sites of coronary stenting in humans: macroscopic, histological, and immuno-histochemical analysis. Circulation 1998; 98: 224-33.
7. Kitamura K, Kangawa K, Kawamoto M, et al. Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem Biophys Res Commun 1993; 192: 553-60.
8. Kitamura K, Kangawa K, Matsuo H, Eto T. Adrenomedullin: implication for hypertension research. Drugs 1995; 49: 485-95.
9. Horio T, Kohno M, Kano H, et al. Adrenomedullin as a novel antimigration factor of vascular smooth muscle cells. Circ Res 1995; 77: 660-64.
10. Kano H, Kohno M, Yasunari K, et al. Adrenomedullin as a novel antiproliferative factor of vascular smooth muscle cells. J Hypertens 1996; 14: 209-13.
11. Isumi Y, Minamino N, Katafuchi T, et al. Adrenomedullin production in fibroblasts: its possible function as a growth regulator of Swiss 3T3 cells. Endocrinology 1998; 139: 2552-63.
12. Iwasaki H, Eguchi S, Shichiri M, Marumo F, Hirata Y. Adrenomedullin as a novel growth-promoting factor for cultured vascular smooth muscle cells: role of tyrosine kinase-mediated mitogen-activated protein kinase activation. Endocrinology 1998; 139: 3432-41.
13. Shimizu K, Tanaka H, Sunamori M, Marumo F, Shichiri M. Adrenomedullin receptor antagonism by calcitonin gene-related peptide (8-37) inhibits carotid artery neointimal hyperplasia after balloon injury. Circ Res 1999; 85: 1199-205.
14. Sumimoto T, Nishikimi T, Mukai M, et al. Plasma adrenomedullin concentrations and cardiac and arterial hypertrophy in hypertension. Hypertension 1997; 30: 741-45.
15. Shinomiya K, Ohmori K, Ohyama H, et al. Association of plasma adrenomedullin with carotid atherosclerosis in chronic ischemic stroke. Peptides 2001; 22: 1873-80.
16. Jougasaki M, Wei CM, Heublein DM, Sandberg SM, Burnett JC Jr. Immunohistochemical localization of adrenomedullin in canine heart and aorta. Peptides 1995; 16: 773-75.
17. Miyao Y, Nishikimi T, Goto Y, et al. Increased plasma adrenomedullin levels in patients with acute myocardial infarction in proportion to the clinical severity. Heart 1998; 79: 39-44.
18. Vijay P, Szekely L, Aufiero TX, Sharp TG. Coronary sinus adrenomedullin rises in response to myocardial injury. Clin Sci 1999; 96: 415-20.
19. Etoh T, Doi H, Hanada Y, et al. Cardiac secretion of adrenomedullin by percutaneous transluminal coronary angioplasty. Horm Metab Res 1997; 29: 530-31.
20. Mizuno O, Ikeda U, Hojo Y, Fujikawa H, Katsuki T, Shimada K. Tissue factor expression in coronary circulation as a prognostic factor for late restenosis after coronary angioplasty. Cardiology 2001; 95: 84-89.
21. Hojo Y, Ikeda U, Ohya K, et al. Interaction between monocytes and vascular endothelial cells induces adrenomedullin production. Atherosclerosis 2001; 155: 381-87.
22. Gimple LW, Herrmann HC, Winnford M, Mammen E, for the Ardeparin and Restenosis Study Group. Usefulness of subcutaneous low molecular weight heparin (Ardeparin) for reduction of restenosis after percutaneous transluminal coronary angioplasty. Am J Cardiol 1999; 83: 1524-29.
23. Kitamura K, Kangawa K, Matsuo H, Eto T. Adrenomedullin: implication for hypertension research. Drugs 1995; 49: 485-95.
24. Sugo S, Minamino N, Kangawa K, et al. Endothelial cells actively synthesize and secrete adrenomedullin. Biochem Biophys Res Commun 1994; 201: 1160-66.
25. Kitamura K, Sakata J, Kangawa K, Kojima M, Matsuo H, Eto T. Cloning and characterization of cDNA encoding a precursor for human adrenomedullin. Biochem Biophys Res Commun 1993; 194: 720-25.
26. Isumi Y, Shoji H, Sugo S, et al. Regulation of adrenomedullin production in rat endothelial cells. Endocrinology 1998; 139: 838-46.
27. Sugo S, Minamino N, Shojo H, et al. Interleukin-1, tumor necrosis factor and lipopolysaccharide additively stimulate production of adrenomedullin in vascular smooth muscle cells. Biochem Biophys Res Commun 1995; 207: 25-32.
28. Sugo S, Minamino N, Shojo H, et al. Production and secretion of adrenomedullin from vascular smooth muscle cells: augmented production by tumor necrosis factor-α. Biochem Biophys Res Commun 1994; 203: 719-26.
29. Inoue T, Sakai Y, Hoshi K, Yaguchi I, Fujito T, Morooka S. Lower expression of neutrophil adhesion molecule indicates less vessel wall injury and might explain lower restenosis rate after cutting balloon angioplasty. Circulation 1998; 97: 2511-18.
30. Kowalski J, Kosmider M, Pawlicki L, et al. Complement activates neutrophils during PTCA procedure in patients with unstable angina pectoris. Int J Cardiol 1996; 58: 229-40.
31. Serrano CV, Ramires JAF, Venturinelli M, et al. Coronary angioplasty results in leukocyte and platelet activation with adhesion molecule expression. J Am Coll Cardiol 1997; 29: 1276-83.
32. Blum A, Sclarovsky S, Shohat B. T lymphocyte activation in stable angina pectoris and after percutaneous transluminal coronary angioplasty. Circulation 1995; 91: 20-22.
33. Liuzzo G, Buffon A, Biasucci LM, et al. Enhanced inflammatory response to coronary angioplasty in patients with severe unstable angina. Circulation 1998; 98: 2370-76.
34. Groves PH, Banning AP, Penny WJ, Lewis MJ, Cheadle HA, Newby AC. Kinetics of smooth muscle cell proliferation and intimal thickening in a pig carotid model of balloon injury. Arteriosclerosis 1995; 117: 83-96.
35. Grew PH, Deneke T, Machraoui A, Barmeryer J, Muller KM. Acute and chronic tissue response to coronary stent implantation: pathologic findings in human specimen. J Am Coll Cardiol 2000; 35: 157-63.
36. Ikeda U, Kanbe T, Shimada K. Adrenomedullin increases inducible nitric oxide synthase in rat vascular smooth muscle cells stimulated with interleukin-1. Hypertension 1996; 27: 1240-44.